Welcome to the first participants of the GSK TRPV4 Study, June 2018
![](/research-centres/media/Media,823626,en.png)
Professor Lorcan McGarvey, Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, is conducting a new respiratory research study at the NICRF:
"GSK TRPV4: A placebo-controlled, double-blind (sponsor open), randomised, crossover study to assess the efficacy, safety, and tolerability of GSK2798745 in participants with chronic cough"
Read more about the study here.